ifosfamide has been researched along with Retroperitoneal Neoplasms in 60 studies
Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.
Excerpt | Relevance | Reference |
---|---|---|
"We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 7.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
"To study feasibility, safety and activity of the combination of high-dose long-infusion ifosfamide (HLI) and radiotherapy (RT) as preoperative treatment for resectable localised retroperitoneal sarcoma (RPS)." | 5.19 | Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. ( Bertola, G; Bruzzi, P; Buonadonna, A; Casali, PG; Dani, C; De Paoli, A; De Sanctis, R; Dei Tos, AP; Fiore, M; Giorello, L; Grignani, G; Gronchi, A; Merlo, DF; Navarria, P; Quagliuolo, V; Sanfilippo, R; Sangalli, C; Stacchiotti, S, 2014) |
"Perioperative three cycles of full-dose of anthracycline and ifosfamide should be proposed on an individual basis, in reference sarcoma centres, to high-risk localized STS of limbs or trunk-wall in certain histologies." | 5.12 | What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma? ( Hindi, N; Martin-Broto, J, 2021) |
"This study was designed to assess patterns of recurrence and long-term outcomes of patients undergoing surgery for localized retroperitoneal sarcoma (RPS) after neoadjuvant high dose long-infusion ifosfamide (HLI) and radiotherapy (RT)." | 3.85 | Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303. ( Basso, S; Bertola, G; Bertuzzi, A; Buonadonna, A; Casali, PG; Colombo, C; De Paoli, A; De Sanctis, R; Fiore, M; Giordano, L; Gronchi, A; Marrari, A; Navarria, F; Navarria, P; Quagliuolo, V; Sanfilippo, R; Sangalli, C; Santoro, A, 2017) |
"We report a case of a 61-year-old Asian man with metastatic retroperitoneal liposarcoma who was HBcAb positive and was treated with ifosfamide and dacarbazine, developed HBV reactivation secondary to ifosfamide requiring treatment with tenofovir." | 3.83 | Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma. ( Chaudhry, R; Cheedella, NK; Chhibar, P; Wang, JC; Zhu, Z, 2016) |
"We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 3.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
" The results however, did not show expected treatment efficacy and we raise the idea of paclitaxel dosage relevance in TIP." | 2.71 | Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. ( Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z, 2005) |
"To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS)." | 2.70 | Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. ( Abdel-Rahman, S; Baumert, J; Baur, A; Hiddemann, W; Issels, RD; Krych, M; Lindner, LH; Wendtner, CM, 2002) |
"Ifosfamide was given at the dosage of 2." | 2.67 | Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. ( Faustini, M; Gianni, L; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R, 1992) |
"Histology of the primary germ cell tumor was pure seminoma in 14 (27%), and non-seminoma in 30 (59%)." | 1.36 | [Result of treatment for advanced germ cell tumor in the last decade]. ( Fukuda, H; Fukui, N; Higashi, Y; Hyochi, N; Ichiyanagi, N; Inoue, M; Ishioka, J; Kageyama, Y; Numao, N; Saito, K; Tanak, M, 2010) |
"Retroperitoneal synovial sarcomas are very rare." | 1.33 | Retroperitoneal synovial sarcoma. ( Crişan, D; Domşa, I; Olinici, CD, 2006) |
"Necrosis was found in 22 (38%) of 57 patients, mature teratoma with or without necrosis was found in nine (16%) of 57 patients, and viable cancer with or without additional necrosis or mature teratoma was found in 26 (46%) of 57 patients." | 1.32 | Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. ( Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L, 2004) |
"These were neuroepithelioma, lymphoma, desmoplastic small-cell tumor, melanoma, and clear-cell sarcoma." | 1.29 | Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. ( Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E, 1995) |
"Chemorefractory metastatic germ cell tumors and elevated tumor markers generally indicate inoperable disease." | 1.28 | Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. ( Bosl, GJ; Herr, HW; Morse, MJ; Motzer, RJ; Reuter, V; Sogani, PC; Wood, DP, 1992) |
"12 patients with extensive metastases of malignant testicular tumors and 5 other patients with other rapidly growing metastasizing tumors were treated." | 1.25 | [Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)]. ( Jonas, U; Körner, F; Lund, S, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (6.67) | 18.7374 |
1990's | 17 (28.33) | 18.2507 |
2000's | 16 (26.67) | 29.6817 |
2010's | 19 (31.67) | 24.3611 |
2020's | 4 (6.67) | 2.80 |
Authors | Studies |
---|---|
Nakahashi, K | 1 |
Yokoyama, Y | 1 |
Fukaya, M | 1 |
Igami, T | 1 |
Mizuno, T | 1 |
Yamaguchi, J | 1 |
Onoe, S | 1 |
Watanabe, N | 1 |
Ebata, T | 1 |
Kunte, A | 1 |
Patkar, S | 1 |
Goel, M | 1 |
Squires, MH | 1 |
Politano, S | 1 |
Pollock, RE | 1 |
Chen, JL | 1 |
Grignol, V | 1 |
Hindi, N | 1 |
Martin-Broto, J | 1 |
De Sanctis, R | 2 |
Giordano, L | 1 |
Colombo, C | 2 |
De Paoli, A | 2 |
Navarria, P | 2 |
Sangalli, C | 2 |
Buonadonna, A | 2 |
Sanfilippo, R | 2 |
Bertola, G | 2 |
Fiore, M | 2 |
Marrari, A | 1 |
Navarria, F | 1 |
Bertuzzi, A | 1 |
Casali, PG | 3 |
Basso, S | 1 |
Santoro, A | 1 |
Quagliuolo, V | 2 |
Gronchi, A | 3 |
Tatenuma, T | 1 |
Mizuno, N | 1 |
Jikuya, R | 1 |
Hashizume, A | 1 |
Yasui, M | 1 |
Umemoto, S | 1 |
Kawai, M | 1 |
Hiruma, T | 1 |
Kishida, T | 1 |
Al-Hader, AA | 1 |
Jain, A | 1 |
Al-Nasrallah, N | 1 |
Einhorn, LH | 3 |
Dani, C | 1 |
Merlo, DF | 1 |
Grignani, G | 1 |
Dei Tos, AP | 2 |
Stacchiotti, S | 2 |
Giorello, L | 1 |
Bruzzi, P | 1 |
Sio, TT | 1 |
Vu, CC | 1 |
Sohawon, S | 1 |
Van Houtte, P | 1 |
Thariat, J | 1 |
Novotny, PJ | 1 |
Miller, RC | 1 |
Bar-Sela, G | 1 |
Sagara, K | 1 |
Takayoshi, K | 1 |
Kusumoto, E | 1 |
Uchino, K | 1 |
Matsumura, T | 1 |
Kusaba, H | 1 |
Momosaki, S | 1 |
Ikejiri, K | 1 |
Baba, E | 1 |
Tanaka, H | 1 |
Yuasa, T | 1 |
Fujii, Y | 1 |
Sakura, M | 1 |
Urakami, S | 1 |
Yamamoto, S | 1 |
Masuda, H | 1 |
Fukui, I | 2 |
Yonese, J | 2 |
Nieto, Y | 1 |
Tu, SM | 1 |
Bassett, R | 1 |
Jones, RB | 1 |
Gulbis, AM | 1 |
Tannir, N | 1 |
Kingham, A | 1 |
Ledesma, C | 1 |
Margolin, K | 2 |
Holmberg, L | 1 |
Champlin, R | 1 |
Pagliaro, L | 1 |
Lopes, LF | 1 |
Macedo, CR | 1 |
Aguiar, Sdos S | 1 |
Barreto, JH | 1 |
Martins, GE | 1 |
Sonaglio, V | 1 |
Milone, M | 1 |
Lima, ER | 1 |
Almeida, MT | 1 |
Lopes, PM | 1 |
Watanabe, FM | 1 |
D'Andrea, ML | 1 |
Pianovski, MA | 1 |
Melaragno, R | 1 |
Vianna, SM | 1 |
Moreira, ME | 1 |
Bruniera, P | 1 |
de Oliveira, CZ | 1 |
Tsukamoto, S | 1 |
Kurematsu, Y | 1 |
Honoki, K | 1 |
Kido, A | 1 |
Somekawa, S | 1 |
Kaya, D | 1 |
Sadamitsu, T | 1 |
Fukui, H | 1 |
Tanaka, Y | 1 |
Chhibar, P | 1 |
Zhu, Z | 1 |
Cheedella, NK | 1 |
Chaudhry, R | 1 |
Wang, JC | 1 |
Saponara, M | 1 |
Frapolli, R | 1 |
Tortoreto, M | 1 |
Cominetti, D | 1 |
Provenzano, S | 1 |
Negri, T | 1 |
Dagrada, GP | 1 |
Vincenzi, B | 1 |
Badalamenti, G | 1 |
Zuco, V | 1 |
Renne, SL | 1 |
Collini, P | 1 |
Morosi, C | 1 |
Bello, E | 1 |
Pilotti, S | 1 |
D'Incalci, M | 1 |
Zaffaroni, N | 1 |
Mullah-Ali, A | 1 |
Ramsay, JA | 1 |
Bourgeois, JM | 1 |
Hodson, I | 1 |
Macdonald, P | 1 |
Midia, M | 1 |
Portwine, C | 1 |
Shibuya, T | 1 |
Osada, T | 1 |
Kodani, T | 1 |
Hojo, M | 1 |
Saito, H | 1 |
Ueyama, H | 1 |
Kato, J | 1 |
Nagahara, A | 1 |
Otaka, M | 1 |
Ogihara, T | 1 |
Nagao, K | 1 |
Fujime, M | 1 |
Watanabe, S | 1 |
Yokoi, M | 1 |
Hosokawa, K | 1 |
Funaki, H | 1 |
Yoshitani, S | 1 |
Kinami, S | 1 |
Omote, K | 1 |
Ueda, N | 1 |
Nakano, Y | 1 |
Kosaka, T | 1 |
Minato, H | 1 |
Ishioka, J | 1 |
Kageyama, Y | 1 |
Inoue, M | 1 |
Fukui, N | 1 |
Numao, N | 1 |
Saito, K | 1 |
Ichiyanagi, N | 1 |
Tanak, M | 1 |
Hyochi, N | 1 |
Fukuda, H | 1 |
Higashi, Y | 1 |
Yamashita, T | 1 |
Morozumi, M | 1 |
Takagi, D | 1 |
Yoshinaga, A | 1 |
Ishii, N | 1 |
Matsuda, T | 1 |
Terao, T | 1 |
Yamada, T | 1 |
Issels, RD | 2 |
Lindner, LH | 2 |
Verweij, J | 1 |
Wust, P | 1 |
Reichardt, P | 1 |
Schem, BC | 1 |
Abdel-Rahman, S | 2 |
Daugaard, S | 1 |
Salat, C | 1 |
Wendtner, CM | 2 |
Vujaskovic, Z | 1 |
Wessalowski, R | 1 |
Jauch, KW | 1 |
Dürr, HR | 1 |
Ploner, F | 1 |
Baur-Melnyk, A | 1 |
Mansmann, U | 1 |
Hiddemann, W | 2 |
Blay, JY | 2 |
Hohenberger, P | 1 |
Daugaard, G | 1 |
Skoneczna, I | 1 |
Aass, N | 1 |
De Wit, R | 1 |
De Santis, M | 1 |
Dumez, H | 1 |
Marreaud, S | 1 |
Collette, L | 1 |
Lluch, JRG | 1 |
Bokemeyer, C | 3 |
Schmoll, HJ | 2 |
Yoo, SH | 1 |
Kim, KR | 1 |
Hong, SJ | 1 |
Cho, KJ | 1 |
Onesti, E | 1 |
Fabi, A | 1 |
Mingoia, M | 1 |
Savarese, A | 1 |
Anelli, V | 1 |
Koudriavtseva, T | 1 |
Sable, S | 1 |
Gandhi, V | 1 |
Nagral, A | 1 |
Nagral, S | 1 |
Krych, M | 1 |
Baumert, J | 1 |
Baur, A | 1 |
Rick, O | 3 |
Weinknecht, S | 2 |
Schirren, J | 1 |
Pottek, T | 1 |
Hartmann, JT | 1 |
Braun, T | 1 |
Rachud, B | 1 |
Weissbach, L | 2 |
Hartmann, M | 1 |
Siegert, W | 5 |
Beyer, J | 5 |
Yamada, K | 1 |
Sugiura, H | 1 |
Suzuki, Y | 1 |
Takahashi, M | 3 |
Mardiak, J | 1 |
Sálek, T | 1 |
Sycová-Milá, Z | 1 |
Obertová, J | 1 |
Hlavatá, Z | 1 |
Mego, M | 1 |
Recková, M | 1 |
Koza, I | 1 |
Schafmayer, C | 1 |
Egberts, JH | 1 |
Kovács, G | 1 |
Leuschner, I | 1 |
Tepel, J | 1 |
Taue, R | 2 |
Harada, A | 2 |
Katto, K | 1 |
Yamamoto, Y | 2 |
Kishimoto, T | 2 |
Nakatuji, Y | 1 |
Tanimoto, S | 2 |
Oka, N | 1 |
Izaki, H | 2 |
Fukumori, T | 2 |
Nishitani, M | 1 |
Kanayama, HO | 2 |
Nishitani, MA | 1 |
Hayashi, H | 1 |
Domşa, I | 1 |
Crişan, D | 1 |
Olinici, CD | 1 |
Ichihara, K | 1 |
Takahashi, S | 1 |
Takahashi, A | 1 |
Masumori, N | 1 |
Itoh, N | 1 |
Hasegawa, T | 1 |
Takagi, Y | 1 |
Taguchi, K | 1 |
Tsukamoto, T | 1 |
Talarico, F | 1 |
Iusco, D | 1 |
Negri, L | 1 |
Belinelli, D | 1 |
Kattan, J | 1 |
Culine, S | 1 |
Theodore, C | 1 |
Droz, JP | 2 |
Motzer, RJ | 2 |
Rodriguez, E | 1 |
Reuter, VE | 1 |
Bosl, GJ | 2 |
Mazumdar, M | 1 |
Chaganti, RS | 1 |
Strohscheer, I | 1 |
Baurmann, H | 1 |
Oettle, H | 1 |
Zingsem, J | 1 |
Zimmermann, R | 1 |
Huhn, D | 3 |
Gururangan, S | 1 |
Bowman, LC | 1 |
Parham, DM | 1 |
Wilimas, JA | 1 |
Rao, B | 1 |
Pratt, CB | 1 |
Douglass, EC | 1 |
Matsumoto, K | 2 |
Miyajima, Y | 2 |
Numata, S | 1 |
Mori, H | 1 |
Fukuda, M | 2 |
Horibe, K | 2 |
Okubo, Y | 1 |
Sakano, Y | 1 |
Yoshimura, K | 1 |
Maeda, H | 1 |
Yamauchi, T | 1 |
Kawai, T | 1 |
Okumura, S | 1 |
Ishikawa, Y | 1 |
Doroshow, JH | 1 |
Ahn, C | 1 |
Hamasaki, V | 1 |
Leong, L | 1 |
Morgan, R | 1 |
Raschko, J | 1 |
Shibata, S | 1 |
Somlo, G | 1 |
Tetef, M | 1 |
Kingreen, D | 3 |
Krause, M | 1 |
Schleicher, J | 2 |
Schwaner, I | 1 |
Schwella, N | 2 |
Lenz, K | 1 |
Gurm, HS | 1 |
Budd, GT | 1 |
Krusch, A | 1 |
Kirsch, A | 1 |
Fléchon, A | 1 |
Biron, P | 1 |
Philip, I | 1 |
Matsuura, H | 1 |
Sakurai, M | 1 |
Arima, K | 1 |
Fujinami, K | 1 |
Kondoh, K | 1 |
Kondoh, I | 1 |
Miura, T | 1 |
Kushida, K | 1 |
Ganjoo, KN | 1 |
Chan, RJ | 1 |
Sharma, M | 1 |
Neda, H | 1 |
Maeda, M | 1 |
Moriya, H | 1 |
Inohara, T | 1 |
Fujita, T | 1 |
Doi, T | 1 |
Nakajima, T | 1 |
Tanaka, I | 1 |
Ohhira, N | 1 |
Takeda, M | 1 |
Gotoh, M | 1 |
Kondo, M | 1 |
Inaba, J | 1 |
Miyashita, Y | 1 |
Lassmann, J | 1 |
Wille, A | 1 |
Wiechen, K | 1 |
Taupitz, M | 1 |
Loening, SA | 1 |
Körner, F | 1 |
Lund, S | 1 |
Jonas, U | 1 |
Pizzocaro, G | 1 |
Salvioni, R | 1 |
Piva, L | 1 |
Faustini, M | 1 |
Nicolai, N | 1 |
Gianni, L | 1 |
Wood, DP | 1 |
Herr, HW | 1 |
Reuter, V | 1 |
Sogani, PC | 1 |
Morse, MJ | 1 |
Kreuser, ED | 1 |
Jaeger, N | 2 |
Altwein, JE | 1 |
Egghart, G | 1 |
Hartlapp, J | 1 |
Gaus, W | 1 |
Schreml, W | 1 |
Hartlapp, JH | 1 |
Vahlensieck, W | 1 |
Loehrer, PJ | 1 |
Williams, SD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors[NCT00936936] | Phase 2 | 64 participants (Actual) | Interventional | 2009-06-02 | Active, not recruiting | ||
Randomized Study Comparing Neoadjuvant Chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) Combined With Regional Hyperthermia (RHT) Versus Neoadjuvant Chemotherapy Alone in the Treatment of High-Risk Soft Tissue Sarcomas in Adults[NCT00003052] | Phase 3 | 340 participants (Anticipated) | Interventional | 1997-07-31 | Completed | ||
A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer[NCT00003941] | Phase 3 | 222 participants (Anticipated) | Interventional | 1999-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for ifosfamide and Retroperitoneal Neoplasms
Article | Year |
---|---|
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Tri | 2021 |
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; | 2008 |
Primary retroperitoneal dysgerminoma presenting as an adrenal tumor: a case report and literature review.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O | 2012 |
Combined resection and multi-agent adjuvant chemotherapy for intra-abdominal desmoplastic small round cell tumour: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adj | 2007 |
[Primary retroperitoneal pure choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Combined Modality | 1995 |
10 trials available for ifosfamide and Retroperitoneal Neoplasms
Article | Year |
---|---|
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.
Topics: Aged; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Feasibility Studies; Humans; Ifosfamid | 2014 |
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2010 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2011 |
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Et | 2002 |
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Mal | 2005 |
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms | 1995 |
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1994 |
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide | 1997 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bo | 1997 |
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relation | 1992 |
44 other studies available for ifosfamide and Retroperitoneal Neoplasms
Article | Year |
---|---|
A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy.
Topics: Humans; Ifosfamide; Liposarcoma; Male; Middle Aged; Retroperitoneal Neoplasms; Survivors | 2022 |
Inferior Vena Cava (IVC) Resection Without Reconstruction for a Large IVC Leiomyosarcoma.
Topics: Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Middle Aged; Retroperitoneal Neoplasms; Vas | 2022 |
Modern multimodality management of patients with caval leiomyosarcoma: New treatment paradigms and potential molecular insights.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dacarbazine; | 2021 |
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Chemoradiotherapy; Female; Follow-Up Studies; Humans | 2017 |
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etopo | 2018 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin | 2015 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2016 |
Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: a case report.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Doxorubicin; Female; Ga | 2014 |
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Topics: Adult; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide | 2013 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; C | 2015 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Su | 2016 |
Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner's syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Diabetes Insipidus, Neurogenic; Doxo | 2016 |
Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma.
Topics: Antineoplastic Agents, Alkylating; Hepatitis B virus; Humans; Ifosfamide; Liposarcoma; Male; Middle | 2016 |
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cerebellar | 2017 |
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Choriocarcinoma | 2009 |
[A case of retroperitoneal dedifferentiated liposarcoma successfully treated with IFM and CDDP].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Proto | 2009 |
[Result of treatment for advanced germ cell tumor in the last decade].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cis | 2010 |
[Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2010 |
Management of a large retroperitoneal primitive neuroectodermal tumour: 'a multimodal approach'.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2012 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Et | 2004 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomy | 2004 |
[Emergent treatment of a malignant peripheral epineurial tumour].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2006 |
[Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Com | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
Retroperitoneal synovial sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Humans; Ifosfamide; | 2006 |
[Malignant fibrous histiocytoma of the retroperitoneum--review of clinical course and histopathology].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administ | 2006 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma | 1995 |
Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Chil | 1993 |
[Combination chemotherapy of ifosfamide and etoposide for advanced neuroblastoma].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dr | 1995 |
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1996 |
A 47-year-old man with leiomyosarcoma and altered mental status.
Topics: Brain Diseases; Fatal Outcome; Humans; Ifosfamide; Leiomyosarcoma; Male; Methylene Blue; Middle Aged | 1999 |
High-dose chemotherapy in germ cell tumours: a large single centre experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Surviva | 1998 |
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin | 1999 |
[High-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced extragonadal germ cell tumor--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug | 1999 |
[A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 1999 |
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Me | 1999 |
[A case of retroperitoneal malignant fibrous histiocytoma with marked response to cisplatin, ifosfamide and doxorubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Histiocytoma, Benign Fibrous | 2001 |
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Mar | 2001 |
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemo | 2001 |
[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
Topics: Adult; Antineoplastic Agents; Bleomycin; Cell Transformation, Neoplastic; Child; Child, Preschool; D | 1975 |
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, | 1992 |
Bulky germinal tumors: comparison of different induction regimens and significance of residual disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Humans; Ifosfamid | 1985 |
Risk/benefit of treating retroperitoneal teratoid bulky tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Fol | 1989 |
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Female; Humans; Ifosfami | 1986 |